PVSRIPO for Patients With Unresectable Melanoma
Clinical trial NCT03712358 · TERMINATED
Trial details
- NCT number
- NCT03712358
- Sponsor
- Istari Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2021-03-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.